BACKGROUND: Viral hepatitis B and C prevalence in the Roma population of eastern Slovakia is largely unknown. This study aimed to explore the prevalence and associated risk factors of chronic viral hepatitis B and C among Roma living in segregated communities in eastern Slovakia. METHODS: Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants were tested for the presence of HBsAg, anti-HBc IgG and anti-HCV. The risk factors were assessed mainly via a structured questionnaire/interview. RESULTS: Altogether 452 Roma were screened, and 11 were excluded due to missing data. A total of 441 patients were included (mean age 34.7 +/- 9.14 years; 35.2% men). 12.5% of participants were HBsAg positive, 40.4% anti-HBc IgG positive while negative for HBsAg and 47.2% of participants were negative for all serological markers of hepatitis B. Hepatitis C prevalence was very low (0.7%), while 2 out of 3 anti-HCV positive participants were coinfected with hepatitis B. Risk factors for hepatitis B infection were male sex, higher age, tattoo, and previous imprisonment. No difference was found in intravenous drug use, blood transfusions and sexual behaviour. CONCLUSION: More than half of the Roma residing in eastern Slovakia have been infected at one point in life with the hepatitis B virus, and 12.5% are HBsAg positive. Hepatitis C prevalence is very low, which is probably due to very low intravenous drug use.
BACKGROUND:Viral hepatitis B and C prevalence in the Roma population of eastern Slovakia is largely unknown. This study aimed to explore the prevalence and associated risk factors of chronic viral hepatitis B and C among Roma living in segregated communities in eastern Slovakia. METHODS: Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants were tested for the presence of HBsAg, anti-HBc IgG and anti-HCV. The risk factors were assessed mainly via a structured questionnaire/interview. RESULTS: Altogether 452 Roma were screened, and 11 were excluded due to missing data. A total of 441 patients were included (mean age 34.7 +/- 9.14 years; 35.2% men). 12.5% of participants were HBsAg positive, 40.4% anti-HBc IgG positive while negative for HBsAg and 47.2% of participants were negative for all serological markers of hepatitis B. Hepatitis C prevalence was very low (0.7%), while 2 out of 3 anti-HCV positive participants were coinfected with hepatitis B. Risk factors for hepatitis B infection were male sex, higher age, tattoo, and previous imprisonment. No difference was found in intravenous drug use, blood transfusions and sexual behaviour. CONCLUSION: More than half of the Roma residing in eastern Slovakia have been infected at one point in life with the hepatitis B virus, and 12.5% are HBsAg positive. Hepatitis C prevalence is very low, which is probably due to very low intravenous drug use.
Authors: Sylvia Drazilova; Martin Janicko; Pavol Kristian; Ivan Schreter; Branislav Kucinsky; Marek Kozlej; Ivana Hockickova; Peter Jarcuska Journal: Gastroenterol Res Pract Date: 2015-12-29 Impact factor: 2.260
Authors: Sylvia Drazilova; Martin Janicko; Pavol Kristian; Ivan Schreter; Monika Halanova; Ingrid Urbancikova; Andrea Madarasova-Geckova; Maria Marekova; Daniel Pella; Peter Jarcuska Journal: Int J Environ Res Public Health Date: 2018-05-22 Impact factor: 3.390
Authors: Zelmira Macejova; Pavol Kristian; Martin Janicko; Monika Halanova; Sylvia Drazilova; Daniela Antolova; Maria Marekova; Daniel Pella; Andrea Madarasova-Geckova; Peter Jarcuska; HepaMeta Team Journal: Int J Environ Res Public Health Date: 2020-04-29 Impact factor: 3.390
Authors: Sylvia Drazilova; Pavol Kristian; Martin Janicko; Monika Halanova; Dominik Safcak; Patricia Denisa Dorcakova; Maria Marekova; Daniel Pella; Andrea Madarasova-Geckova; Peter Jarcuska Journal: Int J Environ Res Public Health Date: 2020-05-09 Impact factor: 3.390
Authors: Mariia Logoida; Pavol Kristian; Andrea Schreiberova; Patrícia Denisa Lenártová; Veronika Bednárová; Elena Hatalová; Ivana Hockicková; Sylvia Dražilová; Peter Jarčuška; Martin Janičko; Štefan Porhinčák; Monika Halánová Journal: Pathogens Date: 2021-12-24